Scholars@Duke publication: Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma

Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma

Publication , Journal Article

Jr, DCC; Gerber, MC; Gams, RA; Crawford, J; Votaw, ML; Higano, CS; Pruitt, BT; Gould, J

Published in: Leukemia and Lymphoma

1993

Leukemia and Lymphoma

1993

SUPPL.

73 / 79

APA

Chicago

ICMJE

MLA

NLM

Jr, D. C. C., Gerber, M. C., Gams, R. A., Crawford, J., Votaw, M. L., Higano, C. S., … Gould, J. (1993). Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma. Leukemia and Lymphoma, 10(SUPPL.), 73–79.

Jr, D. C. C., M. C. Gerber, R. A. Gams, J. Crawford, M. L. Votaw, C. S. Higano, B. T. Pruitt, and J. Gould. “Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma.” Leukemia and Lymphoma 10, no. SUPPL. (1993): 73–79.

Jr DCC, Gerber MC, Gams RA, Crawford J, Votaw ML, Higano CS, et al. Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma. Leukemia and Lymphoma. 1993;10(SUPPL.):73–9.

Jr, D. C. C., et al. “Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma.” Leukemia and Lymphoma, vol. 10, no. SUPPL., 1993, pp. 73–79.

Jr DCC, Gerber MC, Gams RA, Crawford J, Votaw ML, Higano CS, Pruitt BT, Gould J. Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma. Leukemia and Lymphoma. 1993;10(SUPPL.):73–79.

Leukemia and Lymphoma

1993

SUPPL.

73 / 79